Mn Services Vermogensbeheer B.V. grew its stake in Xylem Inc (NYSE:XYL) by 3.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 101,069 shares of the industrial products company’s stock after buying an additional 3,200 shares during the period. Mn Services Vermogensbeheer B.V. owned approximately 0.06% of Xylem worth $7,988,000 at the end of the most recent reporting period.
Other hedge funds also recently added to or reduced their stakes in the company. Norges Bank purchased a new stake in shares of Xylem in the 4th quarter valued at $251,391,000. Impax Asset Management Group plc boosted its stake in shares of Xylem by 18.3% in the 4th quarter. Impax Asset Management Group plc now owns 4,299,123 shares of the industrial products company’s stock valued at $286,837,000 after purchasing an additional 666,437 shares in the last quarter. Amundi Pioneer Asset Management Inc. boosted its stake in shares of Xylem by 61.3% in the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 1,662,661 shares of the industrial products company’s stock valued at $110,933,000 after purchasing an additional 631,858 shares in the last quarter. Ceredex Value Advisors LLC purchased a new stake in shares of Xylem in the 4th quarter valued at $39,742,000. Finally, Ardevora Asset Management LLP purchased a new stake in shares of Xylem in the 4th quarter valued at $35,408,000. 86.94% of the stock is owned by institutional investors and hedge funds.
In related news, insider Tomas Brannemo sold 559 shares of the stock in a transaction dated Thursday, February 21st. The shares were sold at an average price of $74.44, for a total transaction of $41,611.96. Following the sale, the insider now directly owns 10,568 shares of the company’s stock, valued at approximately $786,681.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Claudia S. Toussaint sold 8,215 shares of the stock in a transaction dated Wednesday, March 6th. The shares were sold at an average price of $76.37, for a total transaction of $627,379.55. Following the sale, the senior vice president now directly owns 59,008 shares in the company, valued at $4,506,440.96. The disclosure for this sale can be found here. Insiders have sold a total of 68,460 shares of company stock worth $5,403,327 over the last three months. 0.85% of the stock is currently owned by insiders.
A number of equities research analysts recently commented on the stock. ValuEngine upgraded shares of Xylem from a “hold” rating to a “buy” rating in a report on Tuesday, April 23rd. Zacks Investment Research upgraded shares of Xylem from a “sell” rating to a “hold” rating in a report on Saturday, April 13th. Stifel Nicolaus upped their price target on shares of Xylem from $80.00 to $93.00 and gave the company a “buy” rating in a report on Tuesday, April 16th. Janney Montgomery Scott upgraded shares of Xylem from a “neutral” rating to a “buy” rating and set a $86.00 price target for the company in a report on Friday, May 3rd. Finally, Boenning Scattergood reiterated a “buy” rating on shares of Xylem in a report on Friday, March 22nd. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $78.93.
NYSE:XYL opened at $75.51 on Thursday. The stock has a market capitalization of $13.82 billion, a PE ratio of 26.22, a price-to-earnings-growth ratio of 1.44 and a beta of 1.15. The company has a current ratio of 1.44, a quick ratio of 1.02 and a debt-to-equity ratio of 0.73. Xylem Inc has a 1-year low of $60.65 and a 1-year high of $84.41.
Xylem (NYSE:XYL) last released its earnings results on Thursday, May 2nd. The industrial products company reported $0.52 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.58 by ($0.06). Xylem had a return on equity of 19.46% and a net margin of 10.50%. The business had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.25 billion. During the same period in the prior year, the company earned $0.51 earnings per share. The firm’s quarterly revenue was up 1.6% compared to the same quarter last year. On average, analysts forecast that Xylem Inc will post 3.24 EPS for the current fiscal year.
Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.